Cargando…
RNA N6-Methyladenosine-Related Gene Contribute to Clinical Prognostic Impact on Patients With Liver Cancer
Liver cancer (LC) is the fourth leading cause of cancer-related deaths worldwide. There is an urgent need to identify novel and reliable prognostic biomarkers for LC in order to improve patient outcomes. N6-methyladenosine (m6A) is the most common internal modification in eukaryotic mRNA and has bee...
Autores principales: | Wang, Wei, Sun, Bo, Xia, Yang, Sun, Shenghong, He, Chiyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190981/ https://www.ncbi.nlm.nih.gov/pubmed/32391046 http://dx.doi.org/10.3389/fgene.2020.00306 |
Ejemplares similares
-
Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma
por: Qi, Li-Wen, et al.
Publicado: (2021) -
RNA N6-Methyladenosine Regulators Contribute to Tumor Immune Microenvironment and Have Clinical Prognostic Impact in Breast Cancer
por: Mu, Lan-Xin, et al.
Publicado: (2022) -
Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer
por: Na, Zhijing, et al.
Publicado: (2021) -
Prognostic N6-methyladenosine (m6A)-related lncRNA patterns to aid therapy in pancreatic ductal adenocarcinoma
por: Wang, Yuxin, et al.
Publicado: (2022) -
N6-Methyladenosine RNA Methylation Regulators Have Clinical Prognostic Values in Hepatocellular Carcinoma
por: Liu, Wei, et al.
Publicado: (2020)